The Global Teriflunomide Market is anticipated to gain exponential industry growth over the given forecast period of 2022-2028. Teriflunomide is sold under the brand name Aubagio. It is an active metabolite of leflunomide. Teriflunomide was evaluated in a phase 3 clinical trial TEMSO for the treatment of multiple sclerosis (MS). Teriflunomide is an immunomodulatory agent […]
